Project Grant R01TW013369
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Emory University $201,355 on June 1, 2026, under the International Research and Research Training program (CFDA 93.989) to strengthen HIV-associated non-communicable disease research capacity in Mozambican prisons. Emory will integrate screening for five prioritized non-communicable diseases—smoking, substance use disorders, depression, hypertension, and malnutrition—into mass TB...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded Emory University $129,531 on September 1, 2026, under the International Research and Research Training program (CFDA 93.989) to develop and validate artificial intelligence software for type 2 diabetes screening integrated into mobile-based fundus imaging. The recipient will develop AI software capable of detecting type 2 diabetes using smartphone-based retinal images collected from...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded the University of Rochester $908,204 on June 1, 2026, under the International Research and Research Training program (CFDA 93.989) to support mentored research and career development training focused on neurocognitive impairment among HIV-infected and HIV-negative meningitis patients in rural, northern Uganda. The award funds validation of neurocognitive assessment tools to determine...
- The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded the University of Washington $136,800 on August 15, 2026, under the International Research and Research Training program (CFDA 93.989) to establish a tuberculosis research training program in Kenya. The University of Washington will collaborate with the University of Nairobi and the Kenya Medical Research Institute to develop and deliver training in TB research across three tracks: a...
- The National Institutes of Health Fogarty International Center awarded Universidade Eduardo Mondlane $250,400 on August 24, 2026, under the International Research and Research Training program (CFDA 93.989) to establish a Global Infectious Diseases research training track at the university in Maputo, Mozambique in partnership with University of California San Diego. The award funds development of a PhD research training program in global infectious diseases focused on malaria and neglected...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, awarded the University of Washington $1,343,164 on July 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research into asymptomatic tuberculosis transmission, infectiousness, and immunology conducted in Nairobi, Kenya. The research investigates the infectiousness spectrum of asymptomatic TB, identifies risk factors for increased...
- The Fogarty International Center of the Department of Health and Human Services awarded The Trustees of Columbia University in the City of New York $578,452 on August 20, 2026, under the International Research and Research Training program (CFDA 93.989) to develop and validate a mobile clinical decision support tool and community health worker training package for integrated screening and management of hypertension and chronic obstructive pulmonary disease in low-literacy, multilingual settings....
- The National Institute of Allergy and Infectious Diseases awarded the University of Washington $670,230 on May 7, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop rapid enzymatic assays for point-of-care HIV drug-level feedback. The award is classified as a Project Grant (R01AI195093). The research addresses adherence barriers among adolescent girls and young women in sub-Saharan Africa, who account for one in four new HIV infections globally. Current...
- The National Heart, Lung, and Blood Institute awarded the Regents of the University of California, San Francisco $2,493,062 on September 20, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to examine implementation, effectiveness, and cost-effectiveness of two strategies for integrating community health worker-facilitated hypertension telehealth into routine primary health centers operated by Kenya's Ministry of Health. The study compares a core implementation...
- The National Institutes of Health Office of the Director awarded Fred Hutchinson Cancer Center $1,000,792 on September 12, 2025, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a hybrid effectiveness-implementation cluster-randomized controlled trial testing telehealth-supported delivery of HIV pre- and post-exposure prophylaxis (PrEP and PEP) at private pharmacies in Kenya. The study will randomize 20 pharmacies across Kisumu and Homa Bay Counties in Western Kenya...
The Department of Health and Human Services National Institutes of Health Fogarty International Center awarded the University of Washington $417,681 on August 20, 2026, under the International Research and Research Training program (CFDA 93.989) to develop and evaluate a Systems Analysis and Improvement Approach to optimize cardiometabolic care delivery for hypertension and type 2 diabetes in central Mozambique. The recipient will apply the SAIA implementation strategy to improve diagnosis and management services for comorbid hypertension and type 2 diabetes by implementing the WHO Package of Essential NCD Interventions. The work includes exploration of patient needs, health system stakeholder requirements, and national policies; refinement of the SAIA-CMD strategy; evaluation of whether the strategy improves clinical outcomes among adults with comorbid conditions; and identification of implementation success drivers and sustainability. The study is framed by the Exploration, Preparation, Implementation and Sustainment (EPIS) framework. Place of performance is Seattle, Washington. The award period runs through May 31, 2031. This is a project grant, the assistance type supporting biomedical and behavioral research conducted internationally to reduce disparities in global health and foster partnerships between U.S. and foreign researchers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $417.7k | 9/2/26 |